Alterity Therapeutics Limited ATHE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 2.40M | 3.34M | 4.27M | 3.87M | 3.49M |
| Total Revenue | 2.40M | 3.34M | 4.27M | 3.87M | 3.49M |
| Cost of Revenue | 179.80K | 142.10K | 105.30K | 93.60K | 82.60K |
| Gross Profit | 2.22M | 3.20M | 4.16M | 3.78M | 3.41M |
| SG&A Expenses | 7.15M | 5.93M | 4.73M | 4.13M | 3.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 190.30K | 167.30K | 144.80K | 100.40K | 56.70K |
| Total Operating Expenses | 19.53M | 17.55M | 15.63M | 14.26M | 12.99M |
| Operating Income | -17.13M | -14.21M | -11.36M | -10.39M | -9.50M |
| Income Before Tax | -15.90M | -12.60M | -9.37M | -8.57M | -7.85M |
| Income Tax Expenses | 76.70K | 80.10K | 83.40K | 63.20K | 43.10K |
| Earnings from Continuing Operations | -15.98 | -12.68 | -9.45 | -8.64 | -7.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.98M | -12.68M | -9.45M | -8.64M | -7.89M |
| EBIT | -17.13M | -14.21M | -11.36M | -10.39M | -9.50M |
| EBITDA | -17.13M | -14.20M | -11.35M | -10.37M | -9.48M |
| EPS Basic | -0.08 | -0.06 | -0.05 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | -0.08 | -0.06 | -0.05 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 841.98M | 774.19M | 706.40M | 609.08M | 511.75M |
| Average Diluted Shares Outstanding | 841.98M | 774.19M | 706.40M | 609.08M | 511.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |